251 related articles for article (PubMed ID: 18259159)
21. Direct to consumer genetic testing.
Hauskeller C
BMJ; 2011 Apr; 342():d2317. PubMed ID: 21511785
[No Abstract] [Full Text] [Related]
22. Truth in testing laws: a shot in the arm for designer gene tests.
van Voorhees A
Health Matrix Clevel; 2006; 16(2):797-829. PubMed ID: 16948256
[No Abstract] [Full Text] [Related]
23. Marketing medical care: the manufacturing of satisfaction.
MacStravic RS
Health Mark Q; 1984 Winter-1985 Spring; 2(2-3):157-70. PubMed ID: 10271086
[No Abstract] [Full Text] [Related]
24. Consumer-centric approach a key to Internet marketing.
Data Strateg Benchmarks; 2000 Sep; 4(9):140-2, 129. PubMed ID: 11116482
[TBL] [Abstract][Full Text] [Related]
25. In search of a coherent framework: options for FDA oversight of genetic tests.
Javitt GH
Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
[No Abstract] [Full Text] [Related]
26. Health education expertise + strong "people skills" = marketing success.
Zufall DL
Healthmarketing; 1984; 3(4):10-1. PubMed ID: 10274438
[No Abstract] [Full Text] [Related]
27. A warning that must not be ignored.
Hudson K
New Sci; 2003 May; 178(2393):5. PubMed ID: 14686409
[No Abstract] [Full Text] [Related]
28. Advertising gone too far?
Quinn C
Mark Health Serv; 2008; 28(4):20-3. PubMed ID: 19157035
[No Abstract] [Full Text] [Related]
29. Withdrawal of Personal Genome Service.
van Rossum LG
JAMA; 2014 Jun; 311(23):2441. PubMed ID: 24938573
[No Abstract] [Full Text] [Related]
30. Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.
Malinowski MJ
Jurimetrics; 2000; 41(1):23-52. PubMed ID: 15744897
[TBL] [Abstract][Full Text] [Related]
31. Withdrawal of Personal Genome Service--reply.
Downing NS; Ross JS
JAMA; 2014 Jun; 311(23):2441-2. PubMed ID: 24938574
[No Abstract] [Full Text] [Related]
32. Achieving black belt excellence in marketing health care.
Novelli WD
J Health Care Mark; 1990 Dec; 10(4):2-7. PubMed ID: 10108697
[No Abstract] [Full Text] [Related]
33. ASHG Statement* on direct-to-consumer genetic testing in the United States.
Hudson K; Javitt G; Burke W; Byers P;
Obstet Gynecol; 2007 Dec; 110(6):1392-5. PubMed ID: 18055737
[No Abstract] [Full Text] [Related]
34. The wide, wild world of genetic testing.
Pollack A
N Y Times Web; 2006 Sep; ():NYT4. PubMed ID: 16972376
[No Abstract] [Full Text] [Related]
35. Unregulated direct-to-consumer marketing and self-referral for screening imaging services: a call to action.
O'Malley PG; Taylor AJ
Arch Intern Med; 2004 Dec 13-27; 164(22):2406-8. PubMed ID: 15596628
[No Abstract] [Full Text] [Related]
36. Reports on the potential dangers of genetic tests sold direct to the public.
Human Genetics Commission
Hum Reprod Genet Ethics; 2003; 9(2):21-2. PubMed ID: 14964207
[No Abstract] [Full Text] [Related]
37. New law could improve consumer confidence in genetic testing.
Rubinstein HG
AHIP Cover; 2008; 49(5):8, 68, 70. PubMed ID: 18822801
[No Abstract] [Full Text] [Related]
38. Direct-to-consumer genetic testing.
Lancet; 2012 Jul; 380(9837):76. PubMed ID: 22794228
[No Abstract] [Full Text] [Related]
39. Commission agrees framework to regulate genetic tests sold direct to consumers.
Mayor S
BMJ; 2010 May; 340():c2752. PubMed ID: 20498157
[No Abstract] [Full Text] [Related]
40. Who speaks for the health consumer?
Fox MH
J Health Care Poor Underserved; 2008 Aug; 19(3):671-6. PubMed ID: 18677063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
